Bicycle Therapeutics plc
Income Statement
| Line Item | FY2017 |
|---|---|
| Revenue | $2.1M |
| Cost of Revenue | — |
| Gross Profit | — |
| Gross Margin | — |
| Operating Expenses | |
| Research & Development | $11.9M |
| SG&A Expense | $6.4M |
| Operating Income | $-16.2M |
| Operating Margin | -787.0% |
| Interest Expense | — |
| Pretax Income | $-16.3M |
| Income Tax Expense | $-23.0K |
| Net Income | $-16.3M |
| Net Margin | -789.3% |
| EPS (Basic) | $-48.81 |
| EPS (Diluted) | $-48.81 |
| Shares Outstanding (Basic) | — |
| Shares Outstanding (Diluted) | — |
| Dividends Per Share | — |